Asian multicenter prospective study of circulating tumor DNA sequencing (A-TRAIN Nasopharyngeal Carcinoma Project)
Nasopharyngeal Carcinoma
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
DR VOON PEI JYE
voonpj@yahoo.com
CONTACT
General line: 082 – 276666
CRC: 082-276820 (Tel)
082-276823 (Fax)
Tiong Lee Len, Admin Manager
leelen.crc@gmail.com (Email)
(Facebook)
An Open-Label, Multicenter Phase 1b/2 Study of Nanatinostat and Valganciclovir in Patients with Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors and in Combination with Pembrolizumab in Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
DR VOON PEI JYE
voonpj@yahoo.com
CONTACT
Fong Yian Ching
A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) + Lenvatinib (E7080/MK-7902) + Chemotherapy Compared with Standard of Care as First-line Intervention in Participants with Metastatic Esophageal Carcinoma
Metastatic Esophageal Squamous Cell Carcinoma
Kuala Lumpur Hospital (HKL)
PRINCIPAL INVESTIGATOR
IBTISAM MUHAMAD NOR
CONTACT
Najihah Binti Hussein
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
Eng Jie Yi
CONTACT
Dafne Diana Gabriel
A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) + Lenvatinib (E7080/MK-7902) + Chemotherapy Compared with Standard of Care as First-line Intervention in Participants with Metastatic Esophageal Carcinoma (LEAP-14)
University of Malaya Medical Centre (UMMC)
PRINCIPAL INVESTIGATOR
Prof Ho Gwo Fuang
CONTACT
SC: Haniesya
General line: 03-79492120